Stay updated on Efficacy of Bempedoic Acid 180mg with PCSK9 Inhibitor: Clinical Trial

Sign up to get notified when there's something new on the Efficacy of Bempedoic Acid 180mg with PCSK9 Inhibitor: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efficacy of Bempedoic Acid 180mg with PCSK9 Inhibitor: Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:36:46.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, representing a change in the percent change from Baseline in LDL-C at Month 1 in a study evaluating the efficacy and safety of Bempedoic Acid (ETC-1002) when added to PCSK9 Inhibitor Therapy.
    Difference
    0.1%
    Check dated 2024-06-06T14:28:59.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 6 to 7, indicating an update in the number of relevant medical or healthcare-related publications or documentation. This change may reflect new research findings or additional data entries in the monitored study or database.
    Difference
    0.2%
    Check dated 2024-05-22T20:53:00.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    8%
    Check dated 2024-04-30T21:51:11.000Z thumbnail image

Stay in the know with updates to Efficacy of Bempedoic Acid 180mg with PCSK9 Inhibitor: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efficacy of Bempedoic Acid 180mg with PCSK9 Inhibitor: Clinical Trial page.